Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis.

ABSTRACT:

Objective

To determine racial/ethnic differences in the use of conventional synthetic or biologic disease-modifying anti-rheumatic drugs (csDMARDs or bDMARDs, respectively) and long-term glucocorticoids (GC) or opioids among beneficiaries of the Social Security Disability Insurance (SSDI) with rheumatoid arthritis (RA) and <65 years old.

Methods

Serial cross-sectional analyses of Centers for Medicare and Medicaid Services claims data (2007, 2011, and 2014) for individuals <65 years old with RA receiving SSDI Medicare and Medicaid, no longer working because they were considered disabled. Generalized estimating equation models were used to determine whether the proportion of patients who used csDMARD, bDMARD, long-term GC, and long-term opioids differed by race/ethnicity.

R

SUBMITTER: Navarro-Millan I 

PROVIDER: S-EPMC8018290 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature